CA2795671A1 - Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto - Google Patents

Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto Download PDF

Info

Publication number
CA2795671A1
CA2795671A1 CA2795671A CA2795671A CA2795671A1 CA 2795671 A1 CA2795671 A1 CA 2795671A1 CA 2795671 A CA2795671 A CA 2795671A CA 2795671 A CA2795671 A CA 2795671A CA 2795671 A1 CA2795671 A1 CA 2795671A1
Authority
CA
Canada
Prior art keywords
skin
treatment
tissue volume
gene
radio frequency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2795671A
Other languages
English (en)
French (fr)
Inventor
David John Weisgerber
Nikki Elizabeth Annunziata
Tia Janinne Maurer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of CA2795671A1 publication Critical patent/CA2795671A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
CA2795671A 2010-04-19 2011-04-19 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto Abandoned CA2795671A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32563310P 2010-04-19 2010-04-19
US61/325,633 2010-04-19
PCT/US2011/033033 WO2011133538A1 (en) 2010-04-19 2011-04-19 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto

Publications (1)

Publication Number Publication Date
CA2795671A1 true CA2795671A1 (en) 2011-10-27

Family

ID=44343224

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2795671A Abandoned CA2795671A1 (en) 2010-04-19 2011-04-19 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto

Country Status (8)

Country Link
EP (1) EP2561092A1 (pt)
JP (1) JP2013527756A (pt)
KR (1) KR20120137407A (pt)
CN (1) CN102869789B (pt)
BR (1) BR112012026870A2 (pt)
CA (1) CA2795671A1 (pt)
MX (1) MX2012012235A (pt)
WO (1) WO2011133538A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9671410B2 (en) 2011-01-16 2017-06-06 The Procter & Gamble Company Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
EP2691539B1 (en) 2011-03-31 2018-04-25 The Procter and Gamble Company Methods for identifying and evaluating skin-active agents effective for treating dandruff
US10418127B2 (en) * 2012-03-30 2019-09-17 The Procter & Gamble Company Method of formulating a skin-lightening composition
EP2859486A2 (en) 2012-06-06 2015-04-15 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
EP2885423B1 (en) 2012-08-15 2017-09-27 The Procter and Gamble Company Systems for identifying and evaluating skin-active agents effective for treating an array of skin disorders
WO2016077327A1 (en) 2014-11-10 2016-05-19 The Procter & Gamble Company Personal care compositions with two benefit phases
CN107106429B (zh) 2014-11-10 2021-06-29 宝洁公司 具有两种有益相的个人护理组合物
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company CLEANER FOR AEROSOL MOUSSE FOAM
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
CN113015904A (zh) 2018-11-29 2021-06-22 宝洁公司 用于筛选个人护理产品的方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755560A (en) 1971-06-30 1973-08-28 Dow Chemical Co Nongreasy cosmetic lotions
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US5525464A (en) 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5547839A (en) 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP0430881A3 (en) 1989-11-29 1991-10-23 Ciba-Geigy Ag Photochromic compounds, process for their preparation and their use
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5366443A (en) 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
EP0636186B1 (en) 1992-04-03 1998-11-25 The Perkin-Elmer Corporation Probe composition and method
US5503980A (en) 1992-11-06 1996-04-02 Trustees Of Boston University Positional sequencing by hybridization
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5470710A (en) 1993-10-22 1995-11-28 University Of Utah Automated hybridization/imaging device for fluorescent multiplex DNA sequencing
GB9401833D0 (en) 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
GB9507238D0 (en) 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US6430446B1 (en) 1995-05-05 2002-08-06 Thermage, Inc. Apparatus for tissue remodeling
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5661028A (en) 1995-09-29 1997-08-26 Lockheed Martin Energy Systems, Inc. Large scale DNA microsequencing device
US6228078B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
ATE298536T1 (de) 1999-03-09 2005-07-15 Thermage Inc Vorichtung zur behandlung von gewebe
US20020087155A1 (en) * 1999-08-30 2002-07-04 Underwood Ronald A. Systems and methods for intradermal collagen stimulation
US6702808B1 (en) 2000-09-28 2004-03-09 Syneron Medical Ltd. Device and method for treating skin
WO2002032332A1 (en) * 2000-10-18 2002-04-25 Mattoli Engineering Ltd. Method and apparatus for plasma skin resurfacing
US6889090B2 (en) 2001-11-20 2005-05-03 Syneron Medical Ltd. System and method for skin treatment using electrical current
US6662054B2 (en) 2002-03-26 2003-12-09 Syneron Medical Ltd. Method and system for treating skin
EP1558339A1 (en) 2002-10-07 2005-08-03 Palomar Medical Technologies, Inc. Apparatus for performing photobiostimulation
US7643883B2 (en) * 2005-01-28 2010-01-05 Syneron Medical Ltd. Device and method for treating skin
SI22738A (sl) * 2008-04-11 2009-10-31 Iskra Medical, D.O.O. Naprava za radiofrekvenčno krožno globinsko terapijo

Also Published As

Publication number Publication date
WO2011133538A1 (en) 2011-10-27
BR112012026870A2 (pt) 2017-01-10
MX2012012235A (es) 2012-11-23
KR20120137407A (ko) 2012-12-20
JP2013527756A (ja) 2013-07-04
CN102869789B (zh) 2015-09-30
CN102869789A (zh) 2013-01-09
EP2561092A1 (en) 2013-02-27

Similar Documents

Publication Publication Date Title
CA2795671A1 (en) Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto
US7276058B2 (en) Method and apparatus for treatment of cutaneous and subcutaneous conditions
Bayat et al. Comparison of the in vitro effects of low-level laser therapy and low-intensity pulsed ultrasound therapy on bony cells and stem cells
Huo et al. Noninvasive electromagnetic fields on keratinocyte growth and migration
US20090317911A1 (en) System and method for photodynamic cell therapy
Karanam et al. An overview of potential novel mechanisms of action underlying Tumor Treating Fields-induced cancer cell death and their clinical implications
ATE490803T1 (de) Vorrichtung zur behandlung von langen interatrialen verzögerungen
WO2007115220A3 (en) Hand-held electrical stimulation device
Feres et al. Effect of low-intensity pulsed ultrasound on the activity of osteoclasts: an in vitro study
Gold Noninvasive skin tightening treatment
EP3328493B1 (en) Hair growth stimulation
MX2010008765A (es) Regulacion de expresion de genes de factor de crecimiento de fibroblastos-2 (fgf-2) en celulas vivas con la aplicacion de campos electricos y electromagnetivos especificos y selectivos.
DE102004017547A1 (de) Verfahren und Vorrichtung zur Anwendung von kohärentem, gepulstem Licht zu therapeutischen Zwecken
Fawzi et al. Fractional carbon dioxide laser is effective in amelioration of pruritus in primary cutaneous amyloidosis: a clinical and biochemical study
JP2013524946A (ja) 哺乳類の皮膚の状態を調節するための、エネルギー及び局所適用組成物の併用
WO2009106969A1 (en) Apparatus for carrying out aesthetic treatments, in particular for the treatment of skin stretch marks
Konstantinović et al. Effects of near-infrared low-level laser stimulation on neuronal excitability
US20230414963A1 (en) Multi-modal skin treatment device
Podolskaya et al. Studying the applicability of a pulsed magnetic field to biological tissues
Forouzanfar The effects of low level laser therapy on the expression of collagen type I gene and proliferation of human gingival fibroblasts (Hgf3-Pi 53): in vitro study
Himes et al. Lymphangioleiomyomatosis (lam) Cell Survival Is Driven By Igf2-Induced Stat3 Activation
Zhang et al. Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer
D'Elia et al. Theta burst and quadripulse repetitive Transcranial Magnetic Stimulation (rTMS) may have therapeutic potentials in migraine prevention: a proof-of-concept study in healthy volunteers and a pilot-trial in migraine patients.
Mattiucci et al. Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis
Himes et al. D108 CELL FATE DECISIONS: SENESCENCE, REPAIR, AND REGENERATION: Lymphangioleiomyomatosis (lam) Cell Survival Is Driven By Igf2-Induced Stat3 Activation

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150609